161 related articles for article (PubMed ID: 27291331)
1. Epidemiological and clinical scenario of chronic liver diseases in Italy: Data from a multicenter nationwide survey.
Sagnelli E; Stroffolini T; Sagnelli C; Smedile A; Morisco F; Furlan C; Babudieri S; Brancaccio G; Coppola N; Gaeta GB; Almasio PL;
Dig Liver Dis; 2016 Sep; 48(9):1066-71. PubMed ID: 27291331
[TBL] [Abstract][Full Text] [Related]
2. The importance of HCV on the burden of chronic liver disease in Italy: a multicenter prevalence study of 9,997 cases.
Sagnelli E; Stroffolini T; Mele A; Almasio P; Coppola N; Ferrigno L; Scolastico C; Onofrio M; Imparato M; Filippini P
J Med Virol; 2005 Apr; 75(4):522-7. PubMed ID: 15714480
[TBL] [Abstract][Full Text] [Related]
3. Study of liver cirrhosis over ten consecutive years in Southern China.
Wang X; Lin SX; Tao J; Wei XQ; Liu YT; Chen YM; Wu B
World J Gastroenterol; 2014 Oct; 20(37):13546-55. PubMed ID: 25309085
[TBL] [Abstract][Full Text] [Related]
4. Etiology of hepatocellular carcinoma in Argentina: results of a multicenter retrospective study.
Fassio E; Míguez C; Soria S; Palazzo F; Gadano A; Adrover R; Landeira G; Fernández N; García D; Barbero R; Perelstein G; Ríos B; Isla R; Civetta E; Pérez Ravier R; Barzola S; Curciarello J; Colombato LA; Jmeniltzky A
Acta Gastroenterol Latinoam; 2009 Mar; 39(1):47-52. PubMed ID: 19408739
[TBL] [Abstract][Full Text] [Related]
5. National survey of hepatocellular carcinoma in heavy drinkers in Japan.
Horie Y; Yamagishi Y; Kajihara M; Kato S; Ishii H
Alcohol Clin Exp Res; 2003 Aug; 27(8 Suppl):32S-36S. PubMed ID: 12960504
[TBL] [Abstract][Full Text] [Related]
6. Gender differences in chronic liver diseases in two cohorts of 2001 and 2014 in Italy.
Sagnelli E; Stroffolini T; Sagnelli C; Pirisi M; Babudieri S; Colloredo G; Russello M; Coppola N; Gaeta GB; Cacopardo B; De Luca M; Almasio PL;
Infection; 2018 Feb; 46(1):93-101. PubMed ID: 29150796
[TBL] [Abstract][Full Text] [Related]
7. Characteristics of liver cirrhosis in Italy: Evidence for a decreasing role of HCV aetiology.
Stroffolini T; Sagnelli E; Gaeta GB; Sagnelli C; Andriulli A; Brancaccio G; Pirisi M; Colloredo G; Morisco F; Furlan C; Almasio PL;
Eur J Intern Med; 2017 Mar; 38():68-72. PubMed ID: 27836249
[TBL] [Abstract][Full Text] [Related]
8. High prevalence of dual or triple infection of hepatitis B, C, and delta viruses among patients with chronic liver disease in Mongolia.
Tsatsralt-Od B; Takahashi M; Nishizawa T; Endo K; Inoue J; Okamoto H
J Med Virol; 2005 Dec; 77(4):491-9. PubMed ID: 16254981
[TBL] [Abstract][Full Text] [Related]
9. Frequency of hepatitis C and D super infection in patients with hepatitis B related complex liver disorders.
Baig S; Siddiqui AA; Ahmed WU; Qureshi H; Arif A
J Coll Physicians Surg Pak; 2009 Nov; 19(11):699-703. PubMed ID: 19889265
[TBL] [Abstract][Full Text] [Related]
10. Hepatitis C virus infection in chronic liver disease in Natal.
Soni PN; Tait DR; Gopaul W; Sathar MA; Simjee AE
S Afr Med J; 1996 Jan; 86(1):80-3. PubMed ID: 8685789
[TBL] [Abstract][Full Text] [Related]
11. The transition in the etiologies of hepatocellular carcinoma-complicated liver cirrhosis in a nationwide survey of Japan.
Enomoto H; Ueno Y; Hiasa Y; Nishikawa H; Hige S; Takikawa Y; Taniai M; Ishikawa T; Yasui K; Takaki A; Takaguchi K; Ido A; Kurosaki M; Kanto T; Nishiguchi S;
J Gastroenterol; 2021 Feb; 56(2):158-167. PubMed ID: 33219410
[TBL] [Abstract][Full Text] [Related]
12. Risk factors analysis for hepatocellular carcinoma in patients with and without cirrhosis: a case-control study of 213 hepatocellular carcinoma patients from India.
Kumar M; Kumar R; Hissar SS; Saraswat MK; Sharma BC; Sakhuja P; Sarin SK
J Gastroenterol Hepatol; 2007 Jul; 22(7):1104-11. PubMed ID: 17559381
[TBL] [Abstract][Full Text] [Related]
13. The role of previous infection of hepatitis B virus in Hbs antigen negative and anti-HCV negative Japanese patients with hepatocellular carcinoma: etiological and molecular biological study.
Matsuzaki Y; Sato M; Saito Y; Karube M; Doy M; Shoda J; Abei M; Tanaka N; Hadama T; Kinoshita M
J Exp Clin Cancer Res; 1999 Sep; 18(3):379-89. PubMed ID: 10606185
[TBL] [Abstract][Full Text] [Related]
14. Decreasing role of HCV and HBV infections as aetiological factors of hepatocellular carcinoma in Italy.
Stroffolini T; Sagnelli E; Sagnelli C; Morisco F; Babudieri S; Furlan C; Pirisi M; Russello M; Smedile A; Pisaturo M; Almasio PL
Infection; 2019 Oct; 47(5):805-810. PubMed ID: 31028627
[TBL] [Abstract][Full Text] [Related]
15. Hepatitis B and C virus infection, alcohol drinking, and hepatocellular carcinoma: a case-control study in Italy. Brescia HCC Study.
Donato F; Tagger A; Chiesa R; Ribero ML; Tomasoni V; Fasola M; Gelatti U; Portera G; Boffetta P; Nardi G
Hepatology; 1997 Sep; 26(3):579-84. PubMed ID: 9303486
[TBL] [Abstract][Full Text] [Related]
16. Trends in burden of cirrhosis and hepatocellular carcinoma by underlying liver disease in US veterans, 2001-2013.
Beste LA; Leipertz SL; Green PK; Dominitz JA; Ross D; Ioannou GN
Gastroenterology; 2015 Nov; 149(6):1471-1482.e5; quiz e17-8. PubMed ID: 26255044
[TBL] [Abstract][Full Text] [Related]
17. High prevalence of hepatitis B virus infection and inferior vena cava obstruction among patients with liver cirrhosis or hepatocellular carcinoma in Nepal.
Shrestha SM; Shrestha S; Shrestha A; Tsuda F; Endo K; Takahashi M; Okamoto H
J Gastroenterol Hepatol; 2007 Nov; 22(11):1921-8. PubMed ID: 17914971
[TBL] [Abstract][Full Text] [Related]
18. Clinical, Epidemiological and Histopathological Aspects in Patients with Hepatocellular Carcinoma Undergoing Liver Transplantation.
Tunissiolli NM; Castanhole-Nunes MMU; Pavarino ÉC; da Silva RF; da Silva RCMA; Maria Goloni-Bertollo E
Asian Pac J Cancer Prev; 2018 Oct; 19(10):2795-2802. PubMed ID: 30360608
[TBL] [Abstract][Full Text] [Related]
19. Clinical significance of hepatitis C virus infection to alcoholics with cirrhosis in Korea.
Kwon SY; Ahn MS; Chang HJ
J Gastroenterol Hepatol; 2000 Nov; 15(11):1282-6. PubMed ID: 11129222
[TBL] [Abstract][Full Text] [Related]
20. Etiology of hepatocellular carcinoma in Italian patients with and without cirrhosis.
Chiesa R; Donato F; Tagger A; Favret M; Ribero ML; Nardi G; Gelatti U; Bucella E; Tomasi E; Portolani N; Bonetti M; Bettini L; Pelizzari G; Salmi A; Savio A; Garatti M; Callea F
Cancer Epidemiol Biomarkers Prev; 2000 Feb; 9(2):213-6. PubMed ID: 10698484
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
